Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
227 hedge funds and large institutions have $2.64B invested in Abiomed Inc in 2015 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 92 increasing their positions, 73 reducing their positions, and 25 closing their positions.
68% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 25
26% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 73
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
8% more funds holding
Funds holding: 210 → 227 (+17)
8% less capital invested
Capital invested by funds: $2.87B → $2.64B (-$229M)
36% less call options, than puts
Call options by funds: $3.42M | Put options by funds: $5.34M
Top Buyers
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$58.4M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$17.9M |
| 3 |
Renaissance Technologies
New York
|
+$17.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.8M |
| 5 |
FAM
Fred Alger Management
New York
|
+$14.2M |
Top Sellers
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$66.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$36.1M |
| 3 |
D.E. Shaw & Co
New York
|
-$29M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$28.8M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$19.5M |
ABMD Hedge Fund Activity: Q2 2015 in Review
227 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2015, worth a combined $2.64B — down 8% from $2.87B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new ABMD positions and 25 closed out — a net gain of 17 holders — while 92 added to existing stakes and 73 trimmed.
The largest buyer was 1832 Asset Management, adding an estimated $58.4M. The largest seller was Essex Woodlands Management, cutting an estimated $66.4M.
- 227 institutional investors held Abiomed Inc (ABMD) as of Q2 2015, up from 210 in Q1 2015.
- Funds reported $2.64B of Abiomed Inc stock for Q2 2015, down 8% quarter-over-quarter.
- 42 funds opened new Abiomed Inc positions in Q2 2015 and 25 closed out, a net change of +17 holders.
- The largest Abiomed Inc buyer in Q2 2015 was 1832 Asset Management, an estimated $58.4M added.
- The largest Abiomed Inc seller in Q2 2015 was Essex Woodlands Management, an estimated $66.4M sold.
Based on aggregated 13F filings for Q2 2015.